Webcast Alert: Tapestry Pharmaceuticals, Inc. Presentation at Informed Investors Biotechnology / Cancer On-line Investor Forum webcast on Thursday, October 6, 2005, 10:00 am ET.BOULDER, Colo. -- Tapestry tapestry, hand-woven fabric of plain weave made without shuttle or drawboy, the design of weft threads being threaded into the warp with fingers or a bobbin. Pharmaceuticals, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : TPPH TPPH Transient Patient, Prisoner Holdee ) will present at the following forum: What: Tapestry Pharmaceuticals, Inc. (NasdaqNM: TPPH) will give a presentation at Informed Investors Biotechnology / Cancer On-line Investors Forum. When: October 6, 2005 @10:00 AM Eastern Time Where: http://www.informedinvestors.com/IIF/IIF_Forum.asp?ForumID=89498 How: Live over the Internet--Simply log on to the web at the address above. Contact: Gordon Link, Chief Financial Officer, glink@tapestrypharma.com , (303)516-8500 If you are unable to attend the live event, the forum will be archived and available via the Informed Investors website at http://www.informedinvestors.com/IIF/IIF_Forum.asp?ForumID=89498 Tapestry Pharmaceuticals, Inc. is a company focused on developing proprietary therapies for the treatment of cancer. The Company is also actively engaged in evaluating new therapeutic agents and related technologies for in-licensing. Tapestry's technical expertise is based upon its ability to identify, chemically alter and produce novel therapeutic compounds derived from natural product sources. Tapestry has developed a novel third generation taxane, TPI (Tracks Per Inch) The measurement of the density of the storage channels on a disk or tape. Track density on magnetic disks has reached 125,000 tpi (125 Ktpi). See bpi, areal density and magnetic disk. 287. In December 2004 the Company filed an IND application, and on January 21, 2005, it was cleared to proceed with clinical trials by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. . In May, 2005 its first TPI 287 Phase I study began. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion